Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03233087

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.

Detailed description

The study aims to investigate the role of candidate biomarkers in the diagnosis and prognosis of AA and AD. In the diagnosis part, we begin with a discovery phase where individually matched case-control study. Patients within each disease outcomes (i.e. AD, AMI, PE, AA without AD and healthy controls) are age and sex matched and retrospectively included.In the prognosis part of the study, patients with confirmed AA and AD are enrolled. The primary outcome is the all-cause mortality based on the death certificates. The secondary outcome is the in-hospital mortality according to the patients'medical records.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2017-07-28
Last updated
2024-06-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03233087. Inclusion in this directory is not an endorsement.